In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...
Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...
but it seems that micronutrient deficiency could be a rare cause of pulmonary hypertension. Relatively frequent in developing countries and mostly in infants, thiamine deficiency should not be ...
Chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis (also called idiopathic pulmonary fibrosis, or IPF) are both serious lifelong diseases that make it hard for you to breathe.
Many people don’t even realize they have hypertension until it’s done serious damage. “Know your blood pressure, know the numbers,” stressed Dr. Randy Zusman of Massachusetts General Hospital, who ...